Free Trial

Beam Therapeutics (BEAM) Insider Trading & Ownership

Beam Therapeutics logo
$19.67 +2.14 (+12.20%)
As of 02:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Beam Therapeutics (NASDAQ:BEAM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$5.82M
Get BEAM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Beam Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BEAM Insider Buying and Selling by Quarter

Beam Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/1/2025Christine BellonInsiderSell5,674$18.35$104,117.90  
4/1/2025Giuseppe CiaramellaPresidentSell7,434$18.35$136,413.90  
4/1/2025John M EvansCEOSell30,663$18.35$562,666.05  
1/30/2025John M EvansCEOSell30,000$26.75$802,500.00  
1/2/2025Christine BellonInsiderSell1,241$24.68$30,627.88  
11/6/2024Giuseppe CiaramellaPresidentSell51,110$26.36$1,347,259.60  
10/14/2024Giuseppe CiaramellaPresidentSell51,110$26.27$1,342,659.70  
10/1/2024Bethany J CavanaghSVPSell289$23.48$6,785.72  
10/1/2024Christine BellonInsiderSell385$23.48$9,039.80  
9/30/2024John M EvansCEOSell60,000$24.60$1,476,000.00  
(Data available from 1/1/2013 forward)

BEAM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Beam Therapeutics includes Amy Simon, Bethany J Cavanagh, Christine Bellon, Fmr Llc, Giuseppe Ciaramella, John M Evans, and Terry-Ann Burrell. Learn more on insiders at BEAM.

3.50% of Beam Therapeutics stock is owned by insiders. Learn more on BEAM's insider holdings.

The following insiders have sold BEAM shares in the last 24 months: Amy Simon ($318,277.21), Bethany J Cavanagh ($6,785.72), Christine Bellon ($203,034.32), Fmr Llc ($48,139.40), Giuseppe Ciaramella ($7,990,256.78), John M Evans ($8,444,183.31), and Terry-Ann Burrell ($174,925.52).

Insiders have sold a total of 617,876 Beam Therapeutics shares in the last 24 months for a total of $17,185,602.26 sold.



This page (NASDAQ:BEAM) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners